SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (419)6/6/2003 7:30:37 AM
From: Icebrg  Read Replies (1) | Respond to of 631
 
Icos, Biogen and LFA-1.

I think one of the interesting aspects here is that Biogen appear to be giving up completely on the development of a small molecule psoriasis drug. Against a more or less validated target, at that. One has to wonder why. I would have thought that it was important for them to try to create some back-cover for Amevive.

Erik